With the decriminalization of adult and private cannabis use, possession, and cultivation in 2018, many have predicted that psilocybin, a chemical found in hallucinogenic fungus (often referred to as “Magic Mushrooms”), would be the next to follow suit. However, the acquisition, use, possession, manufacture, or delivery of Psilocybin is now outlawed in South Africa.
As a result of medical study, an increasing number of governments are decriminalizing the selling of psilocybin (in particular). A multitude of medical studies currently shows that, far from posing an immediate or long-term risk to the person taking it, psilocybin has a variety of medicinal and psychological benefits, including treatment of depression and addiction to habit-forming drugs like cocaine and nicotine. MDMA and psilocybin are still outlawed in South Africa.
PSILOCYBIN MEDICAL RESEARCH
Various medical experts have conducted various types of studies on the medicinal effects of psilocybin. Recent research suggests that psilocybin may have the ability to treat a variety of mental and behavioral diseases. These are some examples: –
Depression (including end-of-life psychological distress); Obsessive-compulsive disorder; III. nicotine addiction; IV. alcohol addiction; V. cocaine addiction; VI. cluster headaches; and VII. cancer-related psychiatric illnesses
Is it possible to find hallucinogenic mushrooms in South Africa?
Psilocybe natalensis is a psilocybin mushroom species in the Hymenogastraceae family. It is native to South Africa. The specific epithet alludes to the species’ type site in Natal. Jochen Gartz, Derek Reid, Michael Smith, and Albert Eicker described the species as new to science in 1995.
Psilocybe mushrooms can be found in Africa?
Panaeolus africanus is a little brown fungus with trace quantities of the hallucinogens psilocybin and psilocin. It has been discovered in central and southern Africa.
